The Yogi Adityanath government has announced plans to establish a comprehensive 8,000-acre healthcare manufacturing ecosystem to position Uttar Pradesh as a major pharmaceutical hub. According to reports from Business Standard, the state has already initiated development of pharma and medical devices manufacturing hubs in Lalitpur and Gautam Buddha Nagar (Noida) districts, encompassing more than 2,400 acres. The mega Lalitpur Pharma Park across nearly 1,818 acres will focus on promoting pharma formulation units, bulk drugs and common infrastructure facilities, as confirmed by a senior 'Invest UP' official. The government is positioning this as a world-class medical manufacturing ecosystem designed to attract investments, boost exports and emerge as a major pharma hub.
The Yamuna Expressway Industrial Development Authority (YEIDA) is developing a 350-acre Medical Device Park in Noida, while a 250-acre Pharma Formulation Park near the Noida International Airport (NIA) is being planned to leverage export connectivity. As reported by Business Standard, these developments are designed to reinforce Uttar Pradesh's emergence as North India's healthcare manufacturing hub. Private companies are also investing in the hinterland, with Jedux Parenterals investing ₹105 crore in a greenfield unit in Barabanki district to manufacture advanced Intravenous (IV) fluid solutions. "Uttar Pradesh is emerging as an investment hub, including in the pharma domain owing to the proactive policies and fast improving infra facilities," said Jitendra Pal Singh, Technical Director, Jedux Parenterals. These companies are catering to both domestic and export markets, with Jedux ranked among India's top 5 IV fluid manufacturers producing about 400,000 bottles per day and exporting to over 10 international markets.
The government has planned to invest ₹2,500 crore in the state's healthcare manufacturing ecosystem, with ₹2,000 crore estimated for the Lalitpur Bulk Drug & Pharma Park and ₹500 crore for the Medical Device Park. According to Business Standard, the government has so far attracted pharma investment proposals totalling ₹38,000 crore. Of these, about 210 investment proposals worth ₹28,000 crore were garnered at the Uttar Pradesh Global Investors' Summit (GIS) in 2023, while 11 memorandums of understanding worth about ₹10,000 crore were inked during the recent Pharma Conclave. These commitments are expected to expand UP's manufacturing capacity, strengthen healthcare supply chains, and generate employment opportunities across the state.
As reported by Business Standard, the country's pharma market is estimated to touch $120 billion by 2030 while Uttar Pradesh accounts for roughly 17 percent of the domestic sales. Ranked among India's top 5 IV fluid manufacturers, Jedux produces about 400,000 bottles per day, exporting to over 10 international markets. The state government's push towards becoming a $1 trillion economy target includes promoting advanced pharmaceuticals as a key growth sector alongside manufacturing and services. These manufacturing hubs are strategically positioned to strengthen the state's position in the global pharmaceutical supply chain and support the broader economic transformation goals.
